MedDataX Logo

Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

NCT ID: NCT01020656

Last Updated: 2009-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

206 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Detachment

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

anticoagulant agents antiplatelet agents vitreoretinal surgery Patients suffered from retinal detachment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 1

patients with no anticoagulants used as the control group

No interventions assigned to this group

group 2

patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol)

No interventions assigned to this group

group 3

patients treated with aspirin

No interventions assigned to this group

group 4

patients treated with clopidogrel therapy

No interventions assigned to this group

group 5

patients treated with both anticoagulant and aspirin medications

No interventions assigned to this group

group 6

patients treated with both anticoagulant and clopidogrel medications

No interventions assigned to this group

group 7

patients treated with both aspirin and clopidogrel medications

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Take or no anticoagulant treatment before surgery,
* Vitreoretinal surgery

Exclusion Criteria

* No surgery
* Anesthetic complication
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Centre Hospitalier Universitaire Dijon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ophthalmology Unit CHU Dijon

Dijon, Burgundy, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MARIE02

Identifier Type: -

Identifier Source: org_study_id